2. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. 2013; Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 173:2039–46. DOI:
10.1001/jamainternmed.2013.9763. PMID:
23999949.
3. Kritsotakis EI, Kontopidou F, Astrinaki E, Roumbelaki M, Ioannidou E, Gikas A. 2017; Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece. Infect Drug Resist. 10:317–28. DOI:
10.2147/IDR.S147459. PMID:
29066921. PMCID:
PMC5644569.
Article
4. Aly NY, Al-Mousa HH. , Al Asar el SM. 2008; Nosocomial infections in a medical-surgical intensive care unit. Med Princ Pract. 17:373–7. DOI:
10.1159/000141500. PMID:
18685276.
Article
5. Ylipalosaari P, Ala-Kokko TI, Laurila J, Ohtonen P, Syrjälä H. 2006; Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study. Crit Care. 10:R66. DOI:
10.1186/cc4902. PMID:
16626503. PMCID:
PMC1550870.
6. Dettenkofer M, Ebner W, Els T, Babikir R, Lucking C, Pelz K, et al. 2001; Surveillance of nosocomial infections in a neurology intensive care unit. J Neurol. 248:959–64. DOI:
10.1007/s004150170048. PMID:
11757959.
Article
7. Cornejo-Juárez P, Vilar-Compte D, Pérez-Jiménez C, Ñamendys-Silva SA, Sandoval-Hernández S, Volkow-Fernández P. 2015; The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. Int J Infect Dis. 31:31–4. DOI:
10.1016/j.ijid.2014.12.022. PMID:
25528484.
Article
9. Wilson AP, Hayman S, Whitehouse T, Cepeda J, Kibbler C, Shaw S, et al. 2007; Importance of the environment for patient acquisition of methicillin-resistant Staphylococcus aureus in the intensive care unit: a baseline study. Crit Care Med. 35:2275–9. DOI:
10.1097/01.CCM.0000284504.89948.6E. PMID:
17944014.
Article
10. Pittet D, Allegranzi B, Sax H, Dharan S, Pessoa-Silva CL, Donaldson L, et al. 2006; Evidence-based model for hand transmission during patient care and the role of improved practices. Lancet Infect Dis. 6:641–52. DOI:
10.1016/S1473-3099(06)70600-4.
Article
11. Montero JG, Lerma FÁ, Galleymore PR, Martínez MP, Rocha LÁ, Gaite FB, et al. 2015; Combatting resistance in intensive care: the multimodal approach of the Spanish ICU "Zero Resistance" program. Crit Care. 19:114. DOI:
10.1186/s13054-015-0800-5. PMID:
25880421. PMCID:
PMC4361202.
Article
12. Rohr U, Kaminski A, Wilhelm M, Jurzik L, Gatermann S, Muhr G. 2009; Colonization of patients and contamination of the patients' environment by MRSA under conditions of single-room isolation. Int J Hyg Environ Health. 212:209–15. DOI:
10.1016/j.ijheh.2008.05.003. PMID:
18667356.
Article
13. Korea Disease Control and Prevention Agency, Korea Centers for Disease Control and Prevention. 2020. 2020 list of legal infectious disease, Korea. List of legal infectious disease, Korea. 2020 ed. Korea Centers for Disease Control and Prevention;Cheongju: p. 92–3. 145-8.
14. Clinical and Laboratory Standards Institute (CLSI). 2020. Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI;Wayne: p. 296.
15. Hayden MK, Blom DW, Lyle EA, Moore CG, Weinstein RA. 2008; Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment. Infect Control Hosp Epidemiol. 29:149–54. DOI:
10.1086/524331. PMID:
18179370.
16. Wilson AP, Smyth D, Moore G, Singleton J, Jackson R, Gant V, et al. 2011; The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care units in two hospitals. Crit Care Med. 39:651–8. DOI:
10.1097/CCM.0b013e318206bc66. PMID:
21242793.
Article
17. Tajeddin E, Rashidan M, Razaghi M, Javadi SS, Sherafat SJ, Alebouyeh M, et al. 2016; The role of the intensive care unit environment and health-care workers in the transmission of bacteria associated with hospital acquired infections. J Infect Public Health. 9:13–23. DOI:
10.1016/j.jiph.2015.05.010. PMID:
26117707.
Article
18. Russotto V, Cortegiani A, Fasciana T, Iozzo P, Raineri SM, Gregoretti C, et al. 2017; What healthcare workers should know about environmental bacterial contamination in the intensive care unit. Biomed Res Int. 2017:6905450. DOI:
10.1155/2017/6905450. PMID:
29214175. PMCID:
PMC5682046.
Article
19. Weinstein RA. 1991; Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med. 91(3B):179S–184S. DOI:
10.1016/0002-9343(91)90366-6.
Article
20. Kim YA, Lee H, Lee K. 2015; Contamination of the hospital environmental by pathogenic bacteria and infection control. Korean J Nosocomial Infect Control. 20:1–6. DOI:
10.14192/kjnic.2015.20.1.1.
Article
21. Morgan DJ, Rogawski E, Thom KA, Johnson JK, Perencevich EN, Shardell M, et al. 2012; Transfer of multidrug-resistant bacteria to healthcare workers' gloves and gowns after patient contact increases with environmental contamination. Crit Care Med. 40:1045–51. DOI:
10.1097/CCM.0b013e31823bc7c8. PMID:
22202707. PMCID:
PMC3534819.
Article
22. Esteves DC, Pereira VC, Souza JM, Keller R, Simões RD, Winkelstroter Eller LK, et al. 2016; Influence of biological fluids in bacterial viability on different hospital surfaces and fomites. Am J Infect Control. 44:311–4. DOI:
10.1016/j.ajic.2015.09.033. PMID:
26577628.
Article
23. Galvin S, Dolan A, Cahill O, Daniels S, Humphreys H. 2012; Microbial monitoring of the hospital environment: why and how? J Hosp Infect. 82:143–51. DOI:
10.1016/j.jhin.2012.06.015. PMID:
23022372.
Article
24. Abreu AC, Tavares RR, Borges A, Mergulhão F, Simões M. 2013; Current and emergent strategies for disinfection of hospital environments. J Antimicrob Chemother. 68:2718–32. DOI:
10.1093/jac/dkt281. PMID:
23869049. PMCID:
PMC7109789.
Article
27. Beloin C, Fernández-Hidalgo N, Lebeaux D. 2017; Understanding biofilm formation in intravascular device-related infections. Intensive Care Med. 43:443–6. DOI:
10.1007/s00134-016-4480-7. PMID:
27497588.
Article
29. Vickery K, Deva A, Jacombs A, Allan J, Valente P, Gosbell IB. 2012; Presence of biofilm containing viable multiresistant organisms despite terminal cleaning on clinical surfaces in an intensive care unit. J Hosp Infect. 80:52–5. DOI:
10.1016/j.jhin.2011.07.007. PMID:
21899921.
Article
30. Akinbobola AB, Sherry L, Mckay WG, Ramage G, Williams C. 2017; Tolerance of Pseudomonas aeruginosa in in-vitro biofilms to high-level peracetic acid disinfection. J Hosp Infect. 97:162–8. DOI:
10.1016/j.jhin.2017.06.024. PMID:
28648453.
Article